Savara Inc Increase (Decrease) in Accounts Payable and Accrued Liabilities
Savara Inc (SVRA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $1.39 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2018-11-07
- Savara Inc increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-09-30 was $1.83M.
- Savara Inc increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-06-30 was $110.00K, a 79.17% decline year-over-year.
- Savara Inc increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-03-31 was -$554.00K, a 142.00% decline year-over-year.
- Savara Inc increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2017-12-31 was $16.00K, a 98.42% decline year-over-year.
- Savara Inc increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $159.00K, a 91.07% decline from fiscal 2016.
- Savara Inc increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was $1.78M.
- Savara Inc increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was -$200.00K, a 108.05% decline from fiscal 2014.
- Savara Inc increase (decrease) in accounts payable and accrued liabilities for fiscal 2014 was $2.48M, a 0.92% decline from fiscal 2013.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 181 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 184 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 187 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 190 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 193 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 196 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 199 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 202 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 205 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 208 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 211 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 214 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.95M derived: sum of 2 quarters · filed 2018-11-07 | $1.39M 10-Q · filed 2018-11-07 | $1.41M derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||||||||
| 2018-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$444.00K 10-Q · filed 2018-08-09 | -$428.00K derived: sum of 3 quarters · filed 2018-08-09 | -$2.13M derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||||||||
| 2018-03-31 | -$554.00K 10-Q · filed 2018-05-09 | -$538.00K derived: sum of 2 quarters · filed 2018-05-09 | -$2.24M derived: sum of 3 quarters · filed 2018-11-07 | -$1.71M derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||||||||
| 2017-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$1.69M derived: sum of 2 quarters · filed 2018-11-07 | -$1.16M derived: sum of 3 quarters · filed 2018-11-07 | $159.00K 10-K · filed 2018-03-14 | ||||||||||||||||
| 2017-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$1.18M derived: sum of 2 quarters · filed 2018-11-07 | $143.00K 10-Q · filed 2018-11-07 | $1.16M derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||||||||
| 2017-06-30 | $528.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.85M 10-Q · filed 2018-08-09 | $2.86M derived: sum of 3 quarters · filed 2018-08-09 | $3.39M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2017-03-31 | $1.32M 10-Q · filed 2018-05-09 | $2.33M derived: sum of 2 quarters · filed 2018-05-09 | $2.87M derived: sum of 3 quarters · filed 2018-05-09 | $4.23M derived: sum of 4 quarters · filed 2018-05-09 | ||||||||||||||||
| 2016-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.55M derived: sum of 2 quarters · filed 2018-03-14 | $2.91M derived: sum of 3 quarters · filed 2018-03-14 | $1.78M 10-K · filed 2018-03-14 | ||||||||||||||||
| 2016-09-30 | $533.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.90M derived: sum of 2 quarters · filed 2017-11-08 | $766.00K 10-Q · filed 2017-11-08 | -$2.90M 10-Q · filed 2016-11-08 | -$2.97M derived: sum of 4 quarters · filed 2018-03-14 | |||||||||||||||
| 2016-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $233.00K 10-Q · filed 2017-08-09 | $668.00K 10-Q · filed 2016-08-09 | -$3.50M derived: sum of 3 quarters · filed 2018-03-14 | -$2.33M derived: sum of 4 quarters · filed 2018-03-14 | |||||||||||||||
| 2016-03-31 | -$1.13M 10-Q · filed 2016-05-06 | -$4.87M derived: sum of 2 quarters · filed 2018-03-14 | -$3.70M derived: sum of 3 quarters · filed 2018-03-14 | -$2.07M derived: sum of 4 quarters · filed 2018-03-14 | ||||||||||||||||
| 2015-12-31 | -$3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$2.56M derived: sum of 2 quarters · filed 2018-03-14 | -$933.00K derived: sum of 3 quarters · filed 2018-03-14 | -$200.00K 10-K · filed 2018-03-14 | ||||||||||||||||
| 2015-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $2.80M derived: sum of 2 quarters · filed 2016-11-08 | $3.54M 10-Q · filed 2016-11-08 | $4.41M derived: sum of 4 quarters · filed 2016-11-08 | ||||||||||||||||
| 2015-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.36M 10-Q · filed 2016-08-09 | $3.24M derived: sum of 3 quarters · filed 2016-08-09 | $5.05M derived: sum of 4 quarters · filed 2016-08-09 | ||||||||||||||||
| 2015-03-31 | $733.00K 10-Q · filed 2016-05-06 | $1.61M derived: sum of 2 quarters · filed 2016-05-06 | $3.42M derived: sum of 3 quarters · filed 2016-05-06 | $3.28M derived: sum of 4 quarters · filed 2016-05-06 | ||||||||||||||||
| 2014-12-31 | $873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $2.69M derived: sum of 2 quarters · filed 2015-11-12 | $2.55M derived: sum of 3 quarters · filed 2015-11-12 | $2.48M 10-K · filed 2015-03-24 | ||||||||||||||||
| 2014-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.67M derived: sum of 2 quarters · filed 2015-11-12 | $1.61M 10-Q · filed 2015-11-12 | $1.61M 10-Q · filed 2014-10-31 | $2.58M derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||||||
| 2014-06-30 | -$139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$201.00K 10-Q · filed 2015-08-12 | -$200.39K 10-Q · filed 2014-08-11 | $772.36K derived: sum of 3 quarters · filed 2015-08-12 | $1.68M derived: sum of 4 quarters · filed 2015-08-12 | |||||||||||||||
| 2014-03-31 | -$62.00K 10-Q · filed 2015-05-11 | -$62.00K 10-Q · filed 2014-05-05 | $911.36K derived: sum of 2 quarters · filed 2015-05-11 | $1.82M derived: sum of 3 quarters · filed 2015-05-11 | $1.88M derived: sum of 4 quarters · filed 2015-05-11 | $4.74M 10-Q · filed 2014-05-05 | ||||||||||||||
| 2013-12-31 | $973.36K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $1.88M derived: sum of 2 quarters · filed 2015-03-24 | $1.94M derived: sum of 3 quarters · filed 2015-03-24 | $2.51M 10-K · filed 2015-03-24 | $2.51M 10-K · filed 2014-03-26 | $4.80M 10-K · filed 2014-03-26 | ||||||||||||||
| 2013-09-30 | $910.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $970.20K derived: sum of 2 quarters · filed 2014-10-31 | $1.53M 10-Q · filed 2014-10-31 | $1.53M derived: sum of 4 quarters · filed 2014-10-31 | $3.83M 10-Q · filed 2013-11-04 | |||||||||||||||
| 2013-06-30 | $60.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $623.57K 10-Q · filed 2014-08-11 | $523.69K 10-Q · filed 2013-08-05 | $616.55K derived: sum of 3 quarters · filed 2014-08-11 | $697.43K derived: sum of 4 quarters · filed 2014-08-11 | $2.82M 10-Q · filed 2013-08-05 | ||||||||||||||
| 2013-03-31 | $563.44K 10-Q · filed 2014-05-05 | $556.42K derived: sum of 2 quarters · filed 2014-05-05 | $637.30K derived: sum of 3 quarters · filed 2014-05-05 | $1.22M derived: sum of 4 quarters · filed 2014-05-05 | $2.86M 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | -$7.02K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $73.86K derived: sum of 2 quarters · filed 2014-03-26 | $653.96K derived: sum of 3 quarters · filed 2014-03-26 | $120.47K 10-K · filed 2014-03-26 | $2.30M 10-K · filed 2013-03-19 | |||||||||||||||
| 2012-09-30 | $80.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $660.98K derived: sum of 2 quarters · filed 2013-11-04 | $127.48K 10-Q · filed 2013-11-04 | -$27.62K derived: sum of 4 quarters · filed 2013-11-04 | $2.30M 10-Q · filed 2012-11-05 | |||||||||||||||
| 2012-06-30 | $580.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $46.61K 10-Q · filed 2013-08-05 | -$108.49K derived: sum of 3 quarters · filed 2013-08-05 | -$17.91K derived: sum of 4 quarters · filed 2013-08-05 | $2.22M 10-Q · filed 2012-08-06 | |||||||||||||||
| 2012-03-31 | -$533.49K 10-Q · filed 2013-05-15 | -$688.59K derived: sum of 2 quarters · filed 2013-05-15 | -$598.02K derived: sum of 3 quarters · filed 2013-05-15 | -$669.03K derived: sum of 4 quarters · filed 2013-05-15 | $1.64M 10-Q · filed 2012-05-07 | |||||||||||||||
| 2011-12-31 | -$155.10K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-19 | -$64.53K derived: sum of 2 quarters · filed 2013-03-19 | -$135.53K derived: sum of 3 quarters · filed 2013-03-19 | $196.53K 10-K · filed 2013-03-19 | $2.17M 10-K · filed 2012-03-08 | |||||||||||||||
| 2011-09-30 | $90.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $19.57K derived: sum of 2 quarters · filed 2012-11-05 | $351.63K 10-Q · filed 2012-11-05 | $374.75K 10-Q · filed 2011-11-08 | $1.08M derived: sum of 4 quarters · filed 2012-11-05 | $2.35M 10-Q · filed 2011-11-08 | ||||||||||||||
| 2011-06-30 | -$71.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $261.05K 10-Q · filed 2012-08-06 | $986.16K derived: sum of 3 quarters · filed 2012-08-06 | $734.65K derived: sum of 4 quarters · filed 2012-08-06 | $2.24M 10-Q · filed 2011-08-08 | |||||||||||||||
| 2011-03-31 | $332.06K 10-Q · filed 2012-05-07 | $1.06M derived: sum of 2 quarters · filed 2012-05-07 | $805.66K derived: sum of 3 quarters · filed 2012-05-07 | |||||||||||||||||
| 2010-12-31 | $725.11K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | $473.60K derived: sum of 2 quarters · filed 2012-03-08 | -$552.21K 10-K · filed 2012-03-08 | |||||||||||||||||
| 2010-09-30 | -$251.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$1.28M 10-Q · filed 2011-11-08 | ||||||||||||||||||
| 2010-06-30 | -$1.03M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |